P.392 - Analytical validation (based on CLIA & CLSI standards) of utrophin-laminin α2 and MHCd-laminin α2 duplex immunohistochemical assays using Computational Tissue Analysis (cTA™) for evaluation of Duchenne muscular dystrophy therapeutics

Abstract

Peer reviewed

C Faelan, J Tinsley, A Milici, S Moore and J Patterson-Kane

Neuromuscular disorders : NMD, Vol.27, pp.S214-S214

10/2017

DOI: 10.1016/j.nmd.2017.06.432

View Online

Title: Subtitle: P.392 - Analytical validation (based on CLIA & CLSI standards) of utrophin-laminin α2 and MHCd-laminin α2 duplex immunohistochemical assays using Computational Tissue Analysis (cTA™) for evaluation of Duchenne muscular dystrophy therapeutics
Creators: C Faelan - Flagship Biosciences, Westminster, USA
J Tinsley - Summit
A Milici - Flagship Biosciences, Westminster, USA
S Moore - University of Iowa
J Patterson-Kane - Flagship Biosciences, Westminster, USA
Resource Type: Abstract
Publication Details: Neuromuscular disorders : NMD, Vol.27, pp.S214-S214
Publisher: Elsevier B.V
DOI: 10.1016/j.nmd.2017.06.432
ISSN: 0960-8966
eISSN: 1873-2364
Language: English
Date published: 10/2017
Academic Unit: Pathology
Record Identifier: 9984201423102771

26 Record Views